DT.KONSUM REIT-AG/ DE000A14KRD3 /
29/05/2024 9:04:07 | Diferencia - | Volumen | Bid7:38:48 | Ask7:38:48 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
2.8900EUR | - | 0 Volumen de negocios: 0.0000 |
2.8300Volumen de oferta: 360 | 3.1200Tamaño/ Volumen/ Formato de Ask: 360 | 102.3 millonesEUR | 13.75% | 1.12 |
GlobeNewswire
8:35
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
GlobeNewswire
8:30
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire
8:30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
8:30
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
GlobeNewswire
8:30
Combined General Meeting of June 20, 2024 - Availability of the preparatory documents
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página